News Feature | December 29, 2015

Healthcare CRM Platform Raises $42.3M Series C Financing

Christine Kern

By Christine Kern, contributing writer

How CDI Can Save Your Healthcare IT Clients Money

University Hospitals Chooses Evariant To Support Strategic Growth Initiatives

Evariant has announced it has raised a $42.3M Series C financing led by Goldman Sachs, with participation from Series A and B financing leads Health Enterprise Partners and Lightspeed Venture Partners. Additionally, University Hospitals announced it has selected Evariant in order to support their strategic growth initiatives.

“We aim to invest in companies that are market leaders and solve major healthcare pain points by rethinking a traditional approach,” Jason Kreuziger, a Vice President in the Merchant Banking Division of Goldman Sachs, said in the release.

Evariant assists healthcare systems in attracting profitable patient volume and connecting patients with providers around their care in new value-based healthcare delivery models. This platform of software and analytics solutions that reduce the overall cost of care and deliver a better patient experience is attractive to healthcare systems like University Hospitals which are concerned with the bottom line.

“University Hospitals strives to provide exceptional service to our patients throughout all the communities we serve. Improving individual and community health is an essential aspect of our organization’s mission,” said Cindy Zelis, MD, vice president of clinical integration, University Hospitals. “Our partnership with Evariant allows us to continue creating long-term relationships with patients. By better understanding their needs, we can better collaborate in improving individual and community health.”

“It is no secret healthcare systems are facing a variety of complex market challenges. These issues are not going to be solved by a collection of point solutions, but rather by an integrated platform that can scale and address the healthcare markets’ analytics and CRM needs of today and tomorrow,” stated Evariant Chief Executive Officer William Moschella. “Our advances with Big Data and streaming analytics will yield significant market advantages to our customers. We are excited to leverage this additional investment to address core and new healthcare system requirements.”